Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma

被引:95
作者
ChanYeung, M
Chang, JH
Manfreda, J
Ferguson, A
Becker, A
机构
[1] UNIV BRITISH COLUMBIA, DEPT MED, DIV RESP, VANCOUVER, BC, CANADA
[2] UNIV BRITISH COLUMBIA, DEPT PEDIAT, DIV ALLERGY, VANCOUVER, BC V6T 1W5, CANADA
[3] UNIV MANITOBA, DEPT MED, WINNIPEG, MB, CANADA
[4] UNIV MANITOBA, DEPT COMMUNITY HLTH SCI, WINNIPEG, MB R3T 2N2, CANADA
[5] UNIV MANITOBA, DEPT PEDIAT & CHILD HLTH, ALLERGY & CLIN IMMUNOL SECT, WINNIPEG, MB R3T 2N2, CANADA
关键词
D O I
10.1164/ajrccm.154.4.8887581
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Changes in symptom score and peak expiratory flow (PEF) and the use of medications during the first acute exacerbation of asthma were studied in 41 patients and matched controls who took part in a panel study. An acute exacerbation was defined as the presence of at least one of the following: any unscheduled physician visit, visit to an emergency room, or hospitalization for treatment of asthma; a decrease in PEF by 30% from the patient's best reading; an increase in asthma symptoms during the day and night for over 48 h and not responding to usual medications; and the commencement or doubling of the dose of oral or inhaled steroids for any of the foregoing reasons. Data from -9 to -7 d before the onset of an acute exacerbation were taken as the baseline data, with which the values of the subsequent 14 d were compared. Significant increases in symptoms occurred before a significant reduction in PEF. None of the patients had a decrease of more than 30% in PEF before the onset of symptoms. Daily variation in PEF was not significantly increased from the baseline. Our results suggest that PEF monitoring is not as sensitive as a symptom diary for revealing acute exacerbations of asthma, and that a 30% decrease in PEF is too stringent a criterion for defining an acute exacerbation.
引用
收藏
页码:889 / 893
页数:5
相关论文
共 33 条
[1]  
[Anonymous], 1990, BRIT MED J, V301, P651
[2]  
[Anonymous], 1987, Am Rev Respir Dis, V136, P1285
[3]   COMPARISON OF PEAK EXPIRATORY FLOW-RATE AND FEV1 IN ASSESSING BRONCHOMOTOR TONE AFTER CHALLENGES WITH OCCUPATIONAL SENSITIZERS [J].
BERUBE, D ;
CARTIER, A ;
LARCHEVEQUE, J ;
GHEZZO, H ;
MALO, JL .
CHEST, 1991, 99 (04) :831-836
[4]   MITE AND CAT ALLERGEN LEVELS IN HOMES AND SEVERITY OF ASTHMA [J].
CHANYEUNG, M ;
MANFREDA, J ;
DIMICHWARD, H ;
LAM, J ;
FERGUSON, A ;
WARREN, P ;
SIMONS, E ;
BRODER, I ;
CHAPMAN, M ;
PLATTSMILLS, T ;
BECKER, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) :1805-1811
[5]   EVALUATION OF PEAK FLOW AND SYMPTOMS ONLY SELF MANAGEMENT PLANS FOR CONTROL OF ASTHMA IN GENERAL-PRACTICE [J].
CHARLTON, I ;
CHARLTON, G ;
BROOMFIELD, J ;
MULLEE, MA .
BRITISH MEDICAL JOURNAL, 1990, 301 (6765) :1355-1359
[6]   PATIENT USE OF PEAK FLOW MONITORING [J].
CLARK, NM ;
EVANS, D ;
MELLINS, RB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (03) :722-725
[7]   EFFECT OF ATOPY ON THE NATURAL-HISTORY OF SYMPTOMS, PEAK EXPIRATORY FLOW, AND BRONCHIAL RESPONSIVENESS IN 7-YEAR-OLD AND 8-YEAR-OLD CHILDREN WITH COUGH AND WHEEZE - A 12-MONTH LONGITUDINAL-STUDY [J].
CLOUGH, JB ;
WILLIAMS, JD ;
HOLGATE, ST .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (04) :755-760
[8]   BRONCHIAL REACTIVITY TO INHALED HISTAMINE - METHOD AND CLINICAL SURVEY [J].
COCKCROFT, DW ;
KILLIAN, DN ;
MELLON, JJA ;
HARGREAVE, FE .
CLINICAL ALLERGY, 1977, 7 (03) :235-243
[9]  
CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659
[10]   PERSISTING AIRWAY-OBSTRUCTION IN ASYMPTOMATIC CHILDREN WITH ASTHMA WITH NORMAL PEAK EXPIRATORY FLOW-RATES [J].
FERGUSON, AC .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 82 (01) :19-22